Skip to content
The Policy VaultThe Policy Vault

modafinilCareFirst (Caremark)

Excessive sleepiness associated with obstructive sleep apnea (OSA)

Initial criteria

  • The requested drug is being prescribed by, or in consultation with, a sleep specialist.
  • The diagnosis has been confirmed by polysomnography or home sleep apnea test (HSAT) with a technically adequate device.
  • The patient has been receiving treatment for the underlying airway obstruction (continuous positive airway pressure [CPAP] or bilevel positive airway pressure [BIPAP]) for at least one month.
  • The patient will continue to use CPAP or BIPAP after the requested drug is started.

Reauthorization criteria

  • The patient has achieved or maintained a positive response to treatment from baseline.
  • The patient is compliant with using continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BIPAP).

Approval duration

12 months